Praxis Precision Medicines, Inc.
PRAX
$48.09
-$0.69-1.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 338.45% | 270.02% | 249.53% | -16.93% | 20.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 338.45% | 270.02% | 249.53% | -16.93% | 20.97% |
| Cost of Revenue | 146.94% | 111.04% | 75.66% | 19.15% | -17.75% |
| Gross Profit | -143.09% | -106.99% | -70.61% | -19.89% | 18.27% |
| SG&A Expenses | 28.70% | 24.43% | 33.89% | 13.96% | -10.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.75% | 82.17% | 62.02% | 17.50% | -15.57% |
| Operating Income | -104.67% | -79.00% | -58.39% | -17.98% | 15.91% |
| Income Before Tax | -102.85% | -69.54% | -48.30% | -9.77% | 21.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -102.85% | -69.54% | -48.30% | -9.77% | 21.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.85% | -69.54% | -48.30% | -9.77% | 21.13% |
| EBIT | -104.67% | -79.00% | -58.39% | -17.98% | 15.91% |
| EBITDA | -105.17% | -79.38% | -58.65% | -18.04% | 15.96% |
| EPS Basic | -19.64% | 32.69% | 56.59% | 69.41% | 77.34% |
| Normalized Basic EPS | -20.81% | 31.92% | 56.25% | 69.04% | 77.13% |
| EPS Diluted | -19.64% | 32.69% | 56.59% | 69.41% | 77.34% |
| Normalized Diluted EPS | -20.81% | 31.92% | 56.25% | 69.04% | 77.13% |
| Average Basic Shares Outstanding | 60.14% | 114.83% | 172.33% | 197.39% | 252.63% |
| Average Diluted Shares Outstanding | 60.14% | 114.83% | 172.33% | 197.39% | 252.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |